Loading...
Market
How many Shanghai biopharmaceutical companies will complete a novel drug clinical trial by the end of 2024?
2
Resolution / Starting Odds
0 companies • 25%
1 company • 25%
2-3 companies • 25%
4 or more companies • 25%
Clinical trial registries and company press releases
Story
Shanghai Unveils Plan to Boost Biopharmaceutical Industry with CNY100 Million Each in Funding
Jul 31, 2024, 10:27 AM
Shanghai has announced a comprehensive plan to support its biopharmaceutical industry, pledging millions of dollars over five years to reward local drugmakers that break into global markets. The municipal government will provide up to CNY100 million (USD13.8 million) each to companies based in the city for novel drug research, development, and clinical trials. This initiative is part of a broader set of 37 measures aimed at bolstering Shanghai's health care sector.
View original story
Similar markets
10-12 • 25%
13-15 • 25%
16-18 • 25%
19 or more • 25%
0 to 2 • 25%
3 to 5 • 25%
6 to 8 • 25%
More than 8 • 25%
Less than 10 • 25%
10-20 • 25%
21-30 • 25%
More than 30 • 25%
0-1 • 25%
2-3 • 25%
4-5 • 25%
More than 5 • 25%
0-1 • 25%
2-3 • 25%
4-5 • 25%
More than 5 • 25%
None • 25%
1-3 targets • 25%
4-6 targets • 25%
More than 6 targets • 25%
0-5 • 25%
6-10 • 25%
11-15 • 25%
16 or more • 25%
None • 25%
1-2 companies • 25%
3-4 companies • 25%
More than 4 companies • 25%
0-1 companies • 25%
2-3 companies • 25%
4-5 companies • 25%
More than 5 companies • 25%
None • 25%
1-2 • 25%
3-4 • 25%
5 or more • 25%
Dose escalation • 25%
Safety assessment • 25%
Efficacy assessment • 25%
Trial termination • 25%